Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
Department BSD PED - Hematology, Oncology, and Stem Cell Transplantation About the Department The Section of Pediatric Hematology/Oncology provides care for pediatric, adolescent, and young adult
-
Centers, and various medical and surgical services including hematopoietic stem cell and solid organ transplant programs. The laboratory issues approximately 60,000 blood products and performs 2700
-
of protein degradation, nucleocytoplasmic transport, and cell migration, gene expression, mechanisms that guide the morphogenesis of tissues, organs and organisms, stem cells in development and regeneration
-
, epigenetics, cancer genetics, stem cell biology, genetically-engineered mouse, zebrafish models of cancer, apoptosis, DNA repair, cell motility, cancer metabolism, cancer data science and immuno-oncology. In
-
, candidates need to submit the following documents via Interfolio (https://apply.interfolio.com/182370). Please clearly indicate in your COVER LETTER the specific field (Cancer Biology or Stem Cell Biology) for
-
sequencing methods including DNA-sequencing, RNA-sequencing (RNA-seq), ATAC-seq, ChIP-seq, CUT&RUN, CUT&TAG, single-cell ATAC+RNA-seq, among other approaches), analysis of functional screening datasets (i.e
-
experimental systems — from ecosystems to microbiology and developmental biology, from evolution to cell biology, from molecular biology to systems biology, bioinformatics, and genomics. It is always an exciting
-
interested in mammalian stem cell biology, reproduction, and development. They use cutting-edge single-cell, spatial, in vitro, and surgical approaches in multiple model species and in human organoids
-
, Oncology, and Stem Cell Transplant at Columbia Children?s Health, New York-Presbyterian Morgan Stanley Children?s Hospital (MSCH) is one of the oldest and most comprehensive centers in the country focused
-
/ . The Yachie lab (https://yachie-lab.org/ ) develops next-generation molecular technologies that integrate DNA event recording, genome engineering, organoid and stem-cell platforms, and high-throughput